Who is the manufacturer of ds Head 32ch 3.0T?

Invivo Corporation (Business Trade Name: Philips) filed the 510(k) submission for ds Head 32ch 3.0T (K213351).

What is the FDA product code for ds Head 32ch 3.0T?

MOS. It is classified under 21 CFR 892.1000 as a Class 2 device in the Radiology panel.

What is the regulatory pathway for ds Head 32ch 3.0T?

510(k) clearance (submission type: Traditional).

What are the predicate devices for ds Head 32ch 3.0T?

Models HRB-127-32 High Resolution Brain Coil (K082916).

Who can help prepare an FDA 510(k) submission like ds Head 32ch 3.0T?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

ds Head 32ch 3.0T

K213351 · Invivo Corporation (Business Trade Name: Philips) · MOS · Oct 29, 2021 · Radiology

Device Facts

Record ID	K213351
Device Name	ds Head 32ch 3.0T
Applicant	Invivo Corporation (Business Trade Name: Philips)
Product Code	MOS · Radiology
Decision Date	Oct 29, 2021
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 892.1000
Device Class	Class 2
Attributes	Pediatric, 3rd-Party Reviewed

Intended Use

The dS Head 32ch 3.0T MR Coil is intended to be used in conjunction with a Philips 3.0T Magnetic Resonance Scanner to produce diagnostic images of the head on adult and pediatric patients that can be interpreted by a trained physician.

Device Story

The dS Head 32ch 3.0T MR Coil is a receive-only, phased-array radiofrequency (RF) coil; it captures MR signals from the head during scanning on Philips 3.0T MRI systems. The device features a split-housing mechanical design to facilitate patient positioning. As a digital coil, it interfaces with digital MRI scanners via specific cable connectors. The coil is operated by MRI technicians in a clinical setting. The resulting images are transmitted to the scanner console for review by a radiologist to support clinical diagnosis. The device benefits patients by enabling high-resolution head imaging for diagnostic purposes.

Clinical Evidence

Bench testing only. Performance assessed per FDA guidance 'Magnetic Resonance (MR) Receive-only Coil – Performance Criteria for Safety and Performance Based Pathway'. Testing included: NEMA MS 1, 3, 9 and IEC 62464-1 (SNR and uniformity); ANSI/AAMI ES 60601-1 and NEMA MS 14 (surface heating); IEC 60601-1-2 (EMC); IEC 60601-2-33 and AAMI/ANSI ES 60601-1 (electrical/mechanical safety); and ISO 10993 (biocompatibility). Image quality was assessed by a U.S. Board Certified radiologist to confirm diagnostic sufficiency for adult and pediatric populations.

Technological Characteristics

32-channel, receive-only, phased-array RF coil. Digital architecture. Split-housing mechanical design. Compatible with Philips 3.0T MR scanners. Biocompatible materials per ISO 10993. Standards met: NEMA MS 1, 3, 9, 14; IEC 62464-1, 60601-1-2, 60601-2-33; AAMI/ANSI ES 60601-1.

Indications for Use

Indicated for diagnostic imaging of the head in adult and pediatric patients using a Philips 3.0T MR scanner.

Regulatory Classification

Identification

A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).

Special Controls

*Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

Models HRB-127-32 High Resolution Brain Coil (K082916)

Reference Devices

Achieva, Intera, Ingenia, Ingenia CX, Ingenia Elition, and Ingenia Ambition MR Systems (K110151/K193215)

Related Devices

K091114 — TXRX 1.5T CP HEAD COIL; TXRX 3T CP HEAD COIL · Quality Electrodynamics · May 1, 2009
K093689 — 1.5 TESLA 16- CHANNEL RECEIVE-ONLY PHASED- ARRAY HEAD COIL FOR SIEMANS · Mr Medical Solutions, LLC · Aug 31, 2010
K072909 — 1.5T 32-CHANNEL HEAD COIL AND 3T 32-CHANNEL HEAD COIL · Siemens AG Medical Solutions · Oct 31, 2007
K163205 — 48CH Head Coil · Ge Healthcare Coils (Usa Instruments, Inc.) · Jan 12, 2017
K151829 — Atlas SPEEDER Header/Neck · Quality Electrodynamics, LLC · Jul 29, 2015

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue. Invivo Corporation (Business Trade Name: Philips) % Prithul Bom Most Responsible Person Regulatory Technology Services, LLC 1000 Westgate Drive, Suite 510k SAINT PAUL, Minnesota 55114 ## Re: K213351 Trade/Device Name: ds Head 32ch 3.0T Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: Class II Product Code: MOS Dated: October 7, 2021 Received: October 8, 2021 ### Dear Prithul Bom: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part {1}------------------------------------------------ 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known) K213351 Device Name dS Head 32ch 3.0T Indications for Use (Describe) The dS Head 32ch 3.0T MR Coil is intended to be used in conjunction with a Philips 3.0T Magnetic Resonance Scanner to produce diagnostic images of the head on adult and pediatric patients that can be interpreted by a trained physician. Type of Use (Select one or both, as applicable) > Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the word "PHILIPS" in a bold, sans-serif font. The word is written in a bright blue color. The background is white, which makes the blue color of the word stand out. The image is a clear and simple representation of the Philips logo. ## 510(k) Summary K213351 prepared in accordance with 21 CFR §807.92 | Date Prepared: | October 26, 2021 | | | |---------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------|--| | Manufacturer: | Invivo Corporation (Business Trade Name: Philips) 3545 SW 47th Ave Gainesville, FL 32608 Establishment Registration #1056069 | | | | Primary Contact Person: | Sarah Pleaugh Regulatory Affairs Specialist sarah.pleaugh@philips.com | | | | Secondary Contact Person: | Ann Lebar Head of Regulatory Affairs ann.lebar@philips.com | | | | Device Name: | dS Head 32ch 3.0T | | | | Classification: | Classification Name: | Coil, Magnetic Resonance, Specialty | | | | Classification Regulation: | 21 CFR 892.1000 | | | | Classification Panel: | Radiology | | | | Device Class: | Class II | | | | Primary Product Code: | MOS | | | Primary Predicate Device: | Trade name: | Models HRB-127-32 High Resolution Brain Coil | | | | Manufacturer: | Invivo Corporation | | | | 510(k) Clearance: | K082916 | | | | Classification Name: | Coil, Magnetic Resonance, Specialty | | | | Classification Regulation: | 21 CFR 892.1000 | | | | Classification Panel: | Radiology | | | | Device Class: | Class II | | | | Primary Product Code: | MOS | | | Reference Device: | Trade name: | Achieva, Intera, Ingenia, Ingenia CX, Ingenia Elition, and Ingenia Ambition MR Systems | | | | Manufacturer: | Philips Medical Systems Nederland B.V. | | | 510(k) Clearance: | K110151/K193215 | | | | Classification Name: | Magnetic Resonance Diagnostic Device | | | | Classification Regulation: | 21CFR 892.1000 | | | | Classification Panel: | Radiology | | | | Device Class: | Class II | | | | Product Codes: | LNH, LNI, MOS | | | | Device Description: | The subject dS Head 32ch 3.0T Coil is a receive-only, phased-array radiofrequency (RF) coil designed for high-resolution head examinations on adult and pediatric patients. The coil is intended for use with Philips magnetic resonance (MR) scanners with a 3.0 tesla magnetic field strength. | | | | Indications for Use: | The dS Head 32ch 3.0T MR Coil is intended to be used in conjunction with a Philips 3.0T Magnetic Resonance Scanner to produce diagnostic images of the head on adult and pediatric patients that can be interpreted by a trained physician. | | | | Fundamental Scientific Technology: | The subject dS Head 32ch 3.0T MR Coil is similar in design, material, and energy source to the legally marketed predicate device, Models HRB- 127-32 High Resolution Brain Coil (K082916). The subject and predicate devices are based on the following same technological elements: · Prescription use · Coil designs are 32-channel, receive-only, phased array RF coils · Compatible field strength (3.0T) · Decoupling methodology · Patient contacting materials are known materials that have been assessed for compliance with recognized biocompatibility standards · Energy source for the coils is the MRI scanner · Coils designed for imaging the head anatomy · Coil mechanical design is a split housing to facilitate patient positioning · Manufactured for use with Philips MRI scanners The following technological differences exist between the subject and predicate devices: · Predicate device is an analog coil whereas the subject dS Head 32ch 3.0T MR coil is a digital coil. | | | | | · Different system cable connectors to interface with the digital MRI | | | | | scanners. | | | | | These differences in technology are supported by the MR system and digital coil designs cleared in the reference device Philips Ingenia MR Systems (K110151/K193215), as well as the safety and performance testing provided in this submission. The subject coil performs as intended and does not raise new issues of safety or effectiveness. | | | | Summary of Non- Clinical and Clinical Performance Data: | The subject dS Head 32ch 3.0T Coil met all safety and performance criteria outlined in the FDA guidance "Magnetic Resonance (MR) Receive- only Coil – Performance Criteria for Safety and Performance Based Pathway" issued December 11, 2020: | | | | | - Image Signal to Noise and Image Uniformity characterization (NEMA MS 1, 3, 9 and IEC 62464-1) | | | | | - Surface heating (ANSI/AAMI ES 60601-1 and NEMA MS 14) | | | | | - Acquired Image quality was assessed by a U.S. Board Certified radiologist to confirm images produced on the subject coil are sufficient quality for diagnostic use on both adult and pediatric patient populations | | | | | - Presence of decoupling mechanisms | | | | | - EMC – Immunity, electrostatic discharge (IEC 60601-1-2) | | | | | - General electrical/mechanical safety (IEC 60601-2-33 and AAMI/ANSI ES 60601-1) | | | | | - Biocompatibility evaluation (ISO 10993 series) | | | | Substantial Equivalence Conclusion: | Substantial equivalence of the dS Head 32ch 3.0T MR Coil is demonstrated through the Safety and Performance Based Pathway for magnetic resonance (MR) receive-only coils. The subject device has the same indications for use and technological characteristics as the predicate and reference devices. Substantially equivalent performance is demonstrated by meeting all criterion in the guidance "Magnetic Resonance (MR) Receive-only Coil – Performance Criteria for Safety and Performance Based Pathway" issued on December 11, 2020. | | | {4}------------------------------------------------ # PHILIPS {5}------------------------------------------------ ## PHILIPS